Anton Berns
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
-
- Epigenetics and DNA Methylation 5
- CRISPR and Genetic Engineering 3
- RNA modifications and cancer 3
- PI3K/AKT/mTOR signaling in cancer 3
- Oncology 13
- Cancer-related Molecular Pathways 8
- Co-authors
- Jos Jonkers (6 shared papers)Hanneke van der Gulden (3 shared papers)Peter W. Laird (2 shared papers)Rudolf Jaenisch (2 shared papers)Michael A. Rudnicki (1 shared paper)Hein te Riele (3 shared papers)Silvia Marino (4 shared papers)Martin van der Valk (2 shared papers)
- Journals
- Cancer Research (5 papers)Current Biology (2 papers)Genes & Development (2 papers)Development (2 papers)Nucleic Acids Research (2 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Anton Berns
29 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Oncology 1.8k
- Cancer Research 902
- Molecular Biology 3.7k
- Pathology and Forensic Medicine 730
- Genetics 948
Countries citing papers authored by Anton Berns
This map shows the geographic impact of Anton Berns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Berns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Berns more than expected).
Fields of papers citing papers by Anton Berns
This network shows the impact of papers produced by Anton Berns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Berns. The network helps show where Anton Berns may publish in the future.
Co-authors
The 25 scholars most cited alongside Anton Berns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Simplified mammalian DNA isolation procedure Hit paper breakdown → | 1991 | 1336 |
| 2 | Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer Hit paper breakdown → | 2001 | 794 |
| 3 | Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer Hit paper breakdown → | 1995 | 679 |
| 4 | Induction of medulloblastomas inp53-null mutant mice by somatic inactivation ofRbin the external granular layer cells of the cerebellum Hit paper breakdown → | 2000 | 638 |
| 5 | 2001 | 440 | |
| 6 | 2014 | 174 | |
| 7 | 2002 | 157 | |
| 8 | 2008 | 156 | |
| 9 | 2005 | 140 | |
| 10 | 1998 | 122 | |
| 11 | 1996 | 114 | |
| 12 | 1993 | 102 | |
| 13 | 1990 | 96 | |
| 14 | 2002 | 94 | |
| 15 | 2005 | 90 | |
| 16 | 2014 | 71 | |
| 17 | 2007 | 62 | |
| 18 | 2003 | 49 | |
| 19 | 2006 | 35 | |
| 20 | 2010 | 34 |
About Anton Berns
Anton Berns is a scholar working on Molecular Biology, Oncology, Genetics, Pathology and Forensic Medicine and Biotechnology, having authored 29 papers that have together received 5.5k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Epigenetics and DNA Methylation (5 papers), Cancer Research and Treatments (4 papers), Virus-based gene therapy research (3 papers), CRISPR and Genetic Engineering (3 papers), RNA modifications and cancer (3 papers), Cancer Mechanisms and Therapy (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (902 citations), Molecular Biology (3.7k citations), Pathology and Forensic Medicine (730 citations) and Genetics (948 citations). Anton Berns has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Jos Jonkers, Hanneke van der Gulden, Peter W. Laird, Rudolf Jaenisch, Michael A. Rudnicki, Hein te Riele, Silvia Marino, Martin van der Valk, Marc Vooijs and Ralph Meuwissen. Their work appears in journals such as Cancer Research, Current Biology, Genes & Development, Development and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.